Condition: Infective Endocarditis · Sponsor: Nantes University Hospital
The primary objective of this study is to demonstrate that a rifampin-free regimen is non-inferior to the rifampin-containing regimen in terms of all-cause mortality in staphylococcal prosthetic valve endocarditis within 6 months after randomization.
This description comes directly from the study's public registry record.
Raphaël LECOMTE, MD · 02 40 08 31 12 · raphael.lecomte@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CH metropole Savoie, Chambery, GHT Savoie-Belley, Site Aix les Bains | Aix-les-Bains, France | Recruiting |
| CHU Angers | Angers, France | Recruiting |
| CHU Besançon | Besançon, France | Not Yet Recruiting |
| CHU Bordeaux, Cardiologic hospital of Haut lévêque | Bordeaux, France | Recruiting |
| CHU Bordeaux, Haut Lévêque Hospital, Infectious disease department | Bordeaux, France | Recruiting |
| CHU Brest | Brest, France | Recruiting |
| AP-HP, Groupe hospitalier Henri Mondor | Créteil, France | Recruiting |
| CHU Dijon Bourgogne | Dijon, France | Recruiting |
| CHU Grenoble | Grenoble, France | Recruiting |
| CHD Vendée | La Roche-sur-Yon, France | Recruiting |
| CHU Lyon, La Croix-Rousse Hospital, Infective disease department | Lyon, France | Not Yet Recruiting |
| CHU Lyon, Louis Pradel Hospital, Cardiology Institute | Lyon, France | Not Yet Recruiting |
+ 19 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07345325